DEA schedule
Is Auryxia a controlled substance?
Auryxia contains tetraferric tricitrate decahydrate. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Auryxia (tetraferric tricitrate decahydrate) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tetraferric tricitrate decahydrate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Auryxia?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | tetraferric tricitrate decahydrate is not on the list |
Auryxia NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 59922-631 | Auryxia | tablet, film coated | 210 mg/1 | Akebia Therapeutics, Inc. | None |
Questions
Is Auryxia a controlled substance?
No. Auryxia (tetraferric tricitrate decahydrate) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tetraferric tricitrate decahydrate is not on the DEA controlled substances list.
Is Auryxia a narcotic?
No. Auryxia (tetraferric tricitrate decahydrate) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Parenteral Iron Replacement and Phosphate Binder.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.